GA
AGN

Geneva Advisors’s Allergan plc AGN Stock Holding History

Geneva Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$10.5M Buy
43,273
+11,679
+37% +$2.74M 0.18% 90
2017
Q1 		$7.55M Buy
31,594
+21,156
+203% +$4.93M 0.13% 103
2016
Q4 		$2.19M Sell
10,438
-3,961
-28% -$821K 0.04% 192
2016
Q3 		$3.32M Sell
14,399
-595
-4% -$145K 0.06% 149
2016
Q2 		$3.46M Buy
14,994
+3,904
+35% +$900K 0.07% 141
2016
Q1 		$2.97M Sell
11,090
-2,903
-21% -$831K 0.06% 143
2015
Q4 		$4.37M Sell
13,993
-107,539
-88% -$32M 0.08% 116
2015
Q3 		$33M Buy
121,532
+2,824
+2% +$867K 0.67% 50
2015
Q2 		$36M Buy
118,708
+1,606
+1% +$479K 0.64% 56
2015
Q1 		$34.9M Buy
117,102
+75,222
+180% +$21.4M 0.63% 57
2014
Q4 		$10.8M Buy
41,880
+38,171
+1,029% +$9.54M 0.2% 92
2014
Q3 		$895K Buy
3,709
+584
+19% +$131K 0.02% 329
2014
Q2 		$697K Sell
3,125
-275
-8% -$56.9K 0.01% 376
2014
Q1 		$700K Sell
3,400
-70
-2% -$13.9K 0.01% 337
2013
Q4 		$583K Sell
3,470
-225
-6% -$35.2K 0.01% 312
2013
Q3 		$532K Hold
3,695
– – 0.01% 322
2013
Q2 		$466K Buy
+3,695
New +$418K 0.01% 289

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geneva Advisors's AGN Position: Q2 2017 in Review

Geneva Advisors increased its Allergan plc (AGN) stake by 37% in Q2 2017, buying an estimated $2.74M and bringing the position to 43,273 shares worth $10.5M. The position accounts for 0.18% of the portfolio, ranked #90.

Geneva Advisors first reported a position in AGN in Q2 2013 and has held it in 17 quarters since. The position peaked at $36M in Q2 2015. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Geneva Advisors held 43,273 shares of Allergan plc worth $10.5M as of Q2 2017.
  • Geneva Advisors bought 11,679 Allergan plc shares in Q2 2017, an estimated $2.74M.
  • Allergan plc made up 0.18% of Geneva Advisors's portfolio in Q2 2017, its #90 holding.
  • Geneva Advisors first reported a position in Allergan plc in Q2 2013 and has held it in 17 quarters since.
  • Geneva Advisors's Allergan plc position peaked at $36M in Q2 2015.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.